MX2019003678A - Enzimas modificadoras de ácido nucleico guiadas por arn y métodos de uso de estas. - Google Patents
Enzimas modificadoras de ácido nucleico guiadas por arn y métodos de uso de estas.Info
- Publication number
- MX2019003678A MX2019003678A MX2019003678A MX2019003678A MX2019003678A MX 2019003678 A MX2019003678 A MX 2019003678A MX 2019003678 A MX2019003678 A MX 2019003678A MX 2019003678 A MX2019003678 A MX 2019003678A MX 2019003678 A MX2019003678 A MX 2019003678A
- Authority
- MX
- Mexico
- Prior art keywords
- casy
- proteins
- nucleic acids
- acids encoding
- rna
- Prior art date
Links
- 108020004707 nucleic acids Proteins 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 5
- 150000007523 nucleic acids Chemical class 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 108020005004 Guide RNA Proteins 0.000 abstract 4
- 108091033409 CRISPR Proteins 0.000 abstract 1
- 238000010354 CRISPR gene editing Methods 0.000 abstract 1
- 108010042407 Endonucleases Proteins 0.000 abstract 1
- 102000004533 Endonucleases Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente descripción proporciona proteínas CasY, ácidos nucleicos que codifican las proteínas CasY y células hospedadoras modificadas que comprenden las proteínas CasY y/o ácidos nucleicos que las codifican. Las proteínas CasY son útiles en una variedad de aplicaciones que se proporcionan. La presente descripción proporciona ARN guías de CasY que se unen a y proporcionan especificidad de secuencia a las proteínas CasY, ácidos nucleicos que codifican los ARN guías de CasY y células hospedadoras modificadas que comprenden los ARN guías de CasY y/o ácidos nucleicos que los codifican. Los ARN guías de CasY son útiles en una variedad de aplicaciones que se proporcionan. La presente descripción proporciona métodos para identificar una endonucleasa guiada por ARN de CRISPR.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662402849P | 2016-09-30 | 2016-09-30 | |
PCT/US2017/054047 WO2018064352A1 (en) | 2016-09-30 | 2017-09-28 | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019003678A true MX2019003678A (es) | 2020-08-13 |
Family
ID=61760117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019003678A MX2019003678A (es) | 2016-09-30 | 2017-09-28 | Enzimas modificadoras de ácido nucleico guiadas por arn y métodos de uso de estas. |
Country Status (13)
Country | Link |
---|---|
US (2) | US11371062B2 (es) |
EP (1) | EP3532089A4 (es) |
JP (2) | JP7306696B2 (es) |
KR (2) | KR20230169449A (es) |
CN (1) | CN110418647A (es) |
AU (1) | AU2017335883B2 (es) |
BR (1) | BR112019006388A2 (es) |
CA (1) | CA3038982A1 (es) |
EA (1) | EA201990860A1 (es) |
GB (1) | GB2569734B (es) |
IL (1) | IL265599A (es) |
MX (1) | MX2019003678A (es) |
WO (1) | WO2018064352A1 (es) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3613852A3 (en) | 2011-07-22 | 2020-04-22 | President and Fellows of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US20150044192A1 (en) | 2013-08-09 | 2015-02-12 | President And Fellows Of Harvard College | Methods for identifying a target site of a cas9 nuclease |
US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US9737604B2 (en) | 2013-09-06 | 2017-08-22 | President And Fellows Of Harvard College | Use of cationic lipids to deliver CAS9 |
US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
US9228207B2 (en) | 2013-09-06 | 2016-01-05 | President And Fellows Of Harvard College | Switchable gRNAs comprising aptamers |
US9068179B1 (en) | 2013-12-12 | 2015-06-30 | President And Fellows Of Harvard College | Methods for correcting presenilin point mutations |
AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
CA2963820A1 (en) | 2014-11-07 | 2016-05-12 | Editas Medicine, Inc. | Methods for improving crispr/cas-mediated genome-editing |
EP3294896A1 (en) | 2015-05-11 | 2018-03-21 | Editas Medicine, Inc. | Optimized crispr/cas9 systems and methods for gene editing in stem cells |
AU2016276702B2 (en) | 2015-06-09 | 2022-07-28 | Editas Medicine, Inc. | CRISPR/CAS-related methods and compositions for improving transplantation |
AU2016326711B2 (en) | 2015-09-24 | 2022-11-03 | Editas Medicine, Inc. | Use of exonucleases to improve CRISPR/Cas-mediated genome editing |
CN108513575A (zh) | 2015-10-23 | 2018-09-07 | 哈佛大学的校长及成员们 | 核碱基编辑器及其用途 |
EP3433363A1 (en) | 2016-03-25 | 2019-01-30 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
US11236313B2 (en) | 2016-04-13 | 2022-02-01 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
CA3033327A1 (en) | 2016-08-09 | 2018-02-15 | President And Fellows Of Harvard College | Programmable cas9-recombinase fusion proteins and uses thereof |
WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
KR20230169449A (ko) | 2016-09-30 | 2023-12-15 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Rna-가이드된 핵산 변형 효소 및 이의 사용 방법 |
AU2017335890B2 (en) | 2016-09-30 | 2024-05-09 | The Regents Of The University Of California | RNA-guided nucleic acid modifying enzymes and methods of use thereof |
KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
JP2020513783A (ja) * | 2017-01-18 | 2020-05-21 | エクシジョン バイオセラピューティクス インコーポレイテッド | Crispr |
US10995333B2 (en) * | 2017-02-06 | 2021-05-04 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation |
EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
JP2020510439A (ja) | 2017-03-10 | 2020-04-09 | プレジデント アンド フェローズ オブ ハーバード カレッジ | シトシンからグアニンへの塩基編集因子 |
SG11201908658TA (en) | 2017-03-23 | 2019-10-30 | Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
WO2018201086A1 (en) | 2017-04-28 | 2018-11-01 | Editas Medicine, Inc. | Methods and systems for analyzing guide rna molecules |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
WO2018227114A1 (en) | 2017-06-09 | 2018-12-13 | Editas Medicine, Inc. | Engineered cas9 nucleases |
EP3652312A1 (en) | 2017-07-14 | 2020-05-20 | Editas Medicine, Inc. | Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
CN111757937A (zh) | 2017-10-16 | 2020-10-09 | 布罗德研究所股份有限公司 | 腺苷碱基编辑器的用途 |
EP3704239A4 (en) | 2017-11-01 | 2021-08-18 | The Regents of The University of California | CASZ COMPOSITIONS AND METHOD OF USE |
US11970719B2 (en) * | 2017-11-01 | 2024-04-30 | The Regents Of The University Of California | Class 2 CRISPR/Cas compositions and methods of use |
US11807877B1 (en) | 2018-03-22 | 2023-11-07 | National Technology & Engineering Solutions Of Sandia, Llc | CRISPR/Cas activity assays and compositions thereof |
WO2019210005A1 (en) * | 2018-04-24 | 2019-10-31 | Ligandal, Inc. | Methods and compositions for genome editing |
WO2019214604A1 (zh) * | 2018-05-07 | 2019-11-14 | 中国农业大学 | CRISPR/Cas效应蛋白及系统 |
WO2019237032A1 (en) | 2018-06-07 | 2019-12-12 | Arc Bio, Llc | Compositions and methods for making guide nucleic acids |
US20210284981A1 (en) * | 2018-07-24 | 2021-09-16 | The Regents Of The University Of California | Rna-guided nucleic acid modifying enzymes and methods of use thereof |
EP3830301B1 (en) | 2018-08-01 | 2024-05-22 | Mammoth Biosciences, Inc. | Programmable nuclease compositions and methods of use thereof |
WO2020142754A2 (en) | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection |
WO2020150287A1 (en) * | 2019-01-14 | 2020-07-23 | University Of Rochester | Targeted nuclear rna cleavage and polyadenylation with crispr-cas |
EP4219700A1 (en) | 2019-03-07 | 2023-08-02 | The Regents of the University of California | Crispr-cas effector polypeptides and methods of use thereof |
DE112020001342T5 (de) | 2019-03-19 | 2022-01-13 | President and Fellows of Harvard College | Verfahren und Zusammensetzungen zum Editing von Nukleotidsequenzen |
WO2021133829A1 (en) * | 2019-12-23 | 2021-07-01 | The Regents Of The University Of California | Crispr-cas effector polypeptides and methods of use thereof |
KR102651824B1 (ko) * | 2020-01-31 | 2024-03-27 | 현대모비스 주식회사 | 루프 에어백 장치 |
WO2021216772A1 (en) * | 2020-04-21 | 2021-10-28 | Mammoth Biosciences, Inc. | Casy programmable nucleases and rna component systems |
EP4146804A1 (en) | 2020-05-08 | 2023-03-15 | The Broad Institute Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
JP2024501383A (ja) | 2020-12-22 | 2024-01-11 | クロマ・メディシン,インコーポレーテッド | エピジェネティック編集のための組成物および方法 |
CN113151387B (zh) * | 2021-04-16 | 2022-08-16 | 安徽国肽生物科技有限公司 | 一种具有抗氧化和增强免疫功能的鳕鱼皮胶原蛋白肽及其制备方法 |
EP4347818A2 (en) | 2021-06-01 | 2024-04-10 | Arbor Biotechnologies, Inc. | Gene editing systems comprising a crispr nuclease and uses thereof |
WO2023004391A2 (en) | 2021-07-21 | 2023-01-26 | Montana State University | Nucleic acid detection using type iii crispr complex |
CN114921439B (zh) * | 2022-06-16 | 2024-04-26 | 尧唐(上海)生物科技有限公司 | CRISPR-Cas效应子蛋白、其基因编辑系统及应用 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001090337A2 (en) | 2000-05-24 | 2001-11-29 | Third Wave Technologies, Inc. | Detection of rna |
US6773885B1 (en) | 2000-09-29 | 2004-08-10 | Integrated Dna Technologies, Inc. | Compositions and methods for visual ribonuclease detection assays |
US9689031B2 (en) | 2007-07-14 | 2017-06-27 | Ionian Technologies, Inc. | Nicking and extension amplification reaction for the exponential amplification of nucleic acids |
WO2011100749A2 (en) | 2010-02-15 | 2011-08-18 | Cascade Biosystems, Inc. | Methods and materials for detecting viral or microbial infections |
WO2011156795A2 (en) | 2010-06-11 | 2011-12-15 | Pathogenica, Inc. | Nucleic acids for multiplex organism detection and methods of use and making the same |
US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
US8815782B2 (en) | 2011-11-11 | 2014-08-26 | Agilent Technologies, Inc. | Use of DNAzymes for analysis of an RNA sample |
DK3401400T3 (da) | 2012-05-25 | 2019-06-03 | Univ California | Fremgangsmåder og sammensætninger til rna-styret mål-dna-modifikation og til rna-styret transskriptionsmodulering |
EP2971167B1 (en) | 2013-03-14 | 2019-07-31 | Caribou Biosciences, Inc. | Compositions and methods of nucleic acid-targeting nucleic acids |
US9234213B2 (en) | 2013-03-15 | 2016-01-12 | System Biosciences, Llc | Compositions and methods directed to CRISPR/Cas genomic engineering systems |
EP3071695A2 (en) | 2013-11-18 | 2016-09-28 | Crispr Therapeutics AG | Crispr-cas system materials and methods |
US9994831B2 (en) * | 2013-12-12 | 2018-06-12 | The Regents Of The University Of California | Methods and compositions for modifying a single stranded target nucleic acid |
WO2015116686A1 (en) | 2014-01-29 | 2015-08-06 | Agilent Technologies, Inc. | Cas9-based isothermal method of detection of specific dna sequence |
US10323073B2 (en) | 2014-03-20 | 2019-06-18 | UNIVERSITé LAVAL | CRISPR-based methods and products for increasing frataxin levels and uses thereof |
WO2015157534A1 (en) | 2014-04-10 | 2015-10-15 | The Regents Of The University Of California | Methods and compositions for using argonaute to modify a single stranded target nucleic acid |
WO2015191693A2 (en) | 2014-06-10 | 2015-12-17 | Massachusetts Institute Of Technology | Method for gene editing |
CA2958292A1 (en) | 2014-08-19 | 2016-02-25 | President And Fellows Of Harvard College | Rna-guided systems for probing and mapping of nucleic acids |
WO2016094867A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Protected guide rnas (pgrnas) |
WO2016094872A1 (en) | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
WO2016106236A1 (en) | 2014-12-23 | 2016-06-30 | The Broad Institute Inc. | Rna-targeting system |
WO2016123243A1 (en) | 2015-01-28 | 2016-08-04 | The Regents Of The University Of California | Methods and compositions for labeling a single-stranded target nucleic acid |
AU2016279062A1 (en) | 2015-06-18 | 2019-03-28 | Omar O. Abudayyeh | Novel CRISPR enzymes and systems |
EP3666895A1 (en) | 2015-06-18 | 2020-06-17 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
CN108290933A (zh) | 2015-06-18 | 2018-07-17 | 布罗德研究所有限公司 | 降低脱靶效应的crispr酶突变 |
US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
US9580727B1 (en) | 2015-08-07 | 2017-02-28 | Caribou Biosciences, Inc. | Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides |
KR20180133374A (ko) | 2015-10-22 | 2018-12-14 | 더 브로드 인스티튜트, 인코퍼레이티드 | 타입 vi-b crispr 효소 및 시스템 |
US11193127B2 (en) | 2016-01-08 | 2021-12-07 | University Of Georgia Research Foundation, Inc. | Methods for cleaving DNA and RNA molecules |
US11441146B2 (en) | 2016-01-11 | 2022-09-13 | Christiana Care Health Services, Inc. | Compositions and methods for improving homogeneity of DNA generated using a CRISPR/Cas9 cleavage system |
US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
EP3420083A4 (en) | 2016-02-23 | 2019-08-28 | Arc Bio, LLC | METHOD AND COMPOSITIONS FOR TARGET RECOGNITION |
US20190093091A1 (en) | 2016-04-06 | 2019-03-28 | Temple University - Of The Commonwealth System Of Higher Education | Compositions for eradicating flavivirus infections in subjects |
WO2017205668A1 (en) | 2016-05-25 | 2017-11-30 | Arizona Board Of Regents On Behalf Of Arizona State University | Portable, low-cost pathogen detection and strain identification platform |
US10337051B2 (en) | 2016-06-16 | 2019-07-02 | The Regents Of The University Of California | Methods and compositions for detecting a target RNA |
JP7267013B2 (ja) | 2016-06-17 | 2023-05-01 | ザ・ブロード・インスティテュート・インコーポレイテッド | Vi型crisprオルソログ及び系 |
AU2017280353B2 (en) | 2016-06-24 | 2021-11-11 | Inscripta, Inc. | Methods for generating barcoded combinatorial libraries |
US20210166783A1 (en) | 2016-08-17 | 2021-06-03 | The Broad Institute, Inc. | Methods for identifying class 2 crispr-cas systems |
AU2017335890B2 (en) | 2016-09-30 | 2024-05-09 | The Regents Of The University Of California | RNA-guided nucleic acid modifying enzymes and methods of use thereof |
KR20230169449A (ko) | 2016-09-30 | 2023-12-15 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Rna-가이드된 핵산 변형 효소 및 이의 사용 방법 |
CN106701830B (zh) | 2016-12-07 | 2020-01-03 | 湖南人文科技学院 | 一种敲除猪胚胎p66shc基因的方法 |
CA3049961A1 (en) | 2016-12-09 | 2018-06-14 | The Broad Institute, Inc. | Crispr effector system based diagnostics |
WO2018195545A2 (en) | 2017-04-21 | 2018-10-25 | The General Hospital Corporation | Variants of cpf1 (cas12a) with altered pam specificity |
EP4317443A3 (en) | 2017-08-09 | 2024-02-28 | RiceTec, Inc. | Compositions and methods for modifying genomes |
US20200255858A1 (en) | 2017-11-01 | 2020-08-13 | Jillian F. Banfield | Casy compositions and methods of use |
JP2021501611A (ja) | 2017-11-01 | 2021-01-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Cas12c組成物及び使用方法 |
US11970719B2 (en) | 2017-11-01 | 2024-04-30 | The Regents Of The University Of California | Class 2 CRISPR/Cas compositions and methods of use |
EP3704239A4 (en) | 2017-11-01 | 2021-08-18 | The Regents of The University of California | CASZ COMPOSITIONS AND METHOD OF USE |
US10253365B1 (en) | 2017-11-22 | 2019-04-09 | The Regents Of The University Of California | Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs |
AU2018392709A1 (en) | 2017-12-22 | 2020-07-16 | Massachusetts Institute Of Technology | CRISPR effector system based multiplex diagnostics |
-
2017
- 2017-09-28 KR KR1020237041560A patent/KR20230169449A/ko not_active Application Discontinuation
- 2017-09-28 CN CN201780074122.7A patent/CN110418647A/zh active Pending
- 2017-09-28 JP JP2019517246A patent/JP7306696B2/ja active Active
- 2017-09-28 AU AU2017335883A patent/AU2017335883B2/en active Active
- 2017-09-28 CA CA3038982A patent/CA3038982A1/en active Pending
- 2017-09-28 WO PCT/US2017/054047 patent/WO2018064352A1/en active Application Filing
- 2017-09-28 GB GB1905581.3A patent/GB2569734B/en active Active
- 2017-09-28 EP EP17857432.3A patent/EP3532089A4/en active Pending
- 2017-09-28 MX MX2019003678A patent/MX2019003678A/es unknown
- 2017-09-28 US US16/335,630 patent/US11371062B2/en active Active
- 2017-09-28 KR KR1020197012246A patent/KR20190072548A/ko not_active IP Right Cessation
- 2017-09-28 BR BR112019006388A patent/BR112019006388A2/pt unknown
- 2017-09-28 EA EA201990860A patent/EA201990860A1/ru unknown
-
2019
- 2019-03-25 IL IL265599A patent/IL265599A/en unknown
-
2022
- 2022-05-19 US US17/749,017 patent/US20220396812A1/en active Pending
- 2022-12-19 JP JP2022202406A patent/JP2023030067A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3532089A1 (en) | 2019-09-04 |
GB201905581D0 (en) | 2019-06-05 |
WO2018064352A1 (en) | 2018-04-05 |
EP3532089A4 (en) | 2020-05-13 |
BR112019006388A2 (pt) | 2019-06-25 |
CA3038982A1 (en) | 2018-04-05 |
US11371062B2 (en) | 2022-06-28 |
JP2023030067A (ja) | 2023-03-07 |
AU2017335883B2 (en) | 2024-06-13 |
CN110418647A (zh) | 2019-11-05 |
GB2569734B (en) | 2022-09-07 |
IL265599A (en) | 2019-05-30 |
KR20230169449A (ko) | 2023-12-15 |
EA201990860A1 (ru) | 2019-10-31 |
AU2017335883A1 (en) | 2019-04-11 |
GB2569734A (en) | 2019-06-26 |
JP2019534695A (ja) | 2019-12-05 |
KR20190072548A (ko) | 2019-06-25 |
US20220396812A1 (en) | 2022-12-15 |
JP7306696B2 (ja) | 2023-07-11 |
US20190300908A1 (en) | 2019-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2569734A (en) | RNA-guided nucleic acid modifying enzymes and methods of use thereof | |
GB2569733A (en) | RNA-guided nucleic acid modifying enzymes and methods of use thereof | |
WO2019006471A3 (en) | NOVEL CRISPR RNA TARGETING ENZYMES, SYSTEMS AND USES THEREOF | |
WO2016183438A8 (en) | Self-targeting genome editing system | |
MX2020011939A (es) | Nuevas enzimas y sistemas crispr. | |
EP4219704A3 (en) | Aprl-clade protease variants and uses thereof | |
MX2020004578A (es) | Composiciones de casz y metodos de uso. | |
EP4361261A3 (en) | Novel cas13b orthologues crispr enzymes and systems | |
NZ728437A (en) | Methods for increasing cas9-mediated engineering efficiency | |
WO2015160895A3 (en) | Modified transposases for improved insertion sequence bias and increased dna input tolerance | |
MX2017014125A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
MX2018007622A (es) | Mutantes de proteina f de rsv. | |
SG10201804715WA (en) | Crispr hybrid dna/rna polynucleotides and methods of use | |
MX2016011690A (es) | Edicion del genoma sin nucleasas. | |
SG10201805815YA (en) | Rna-guided gene drives | |
MX351310B (es) | Clase novedosa de genes de resistencia a glifosato. | |
MX2022001085A (es) | Anticuerpos anti-c1s humanizados y metodos para usarlos. | |
PH12019500789A1 (en) | Anti-c1s antibodies and methods of use thereof | |
MX2018011980A (es) | 3-epimerasa y polinucleotido que la codifica. | |
EP3964575A3 (en) | Alpha-amylase variants and polynucleotides encoding same | |
WO2016134213A3 (en) | Enhanced protein expression | |
EA202190454A1 (ru) | Новый crispr-ассоциированный белок и его применение | |
MX2021007688A (es) | Metodos para formar poliplejos. | |
TW201614071A (en) | Aptamer specific to colorectal cancer stem cell and application thereof | |
TW201612317A (en) | Gene, composition and method for improving lignocelluloses hydrolyzation |